CHC 2018 Website Header NATIONAL.png

      ·     About      ·     Presentations     ·   Speakers  ·    Agenda    ·    App    ·


 

8th annual Canadian Hematology Conference
Presentations!


DAY 1

Plasma Cell Dyscrasias / Chair: Dr. Peter Anglin

Relapsed Myeloma in 2018


Upfront Treatment of Myeloma in 2018

 

Non-Hodgkin’s Lymphoma / Chair: Dr. Michael Crump

CAR-T in Aggressive Lymphoma


Second Line Therapy of DLBCL - Choices?


Indolent Lymphoma - Re-visiting Chemo-free Therapy


Hodgkin’s Lymphoma / Chair: Dr. John Kuruvilla

How to Treat Advanced HL in 2018


RR HL - Where Does Therapy Go?


The Evolving Role of Radiation in HL


Chronic Lymphocytic Leukemia (CLL) / Chair: Dr. Graeme Fraser

Update on First Line Management on CLL


Relapsed CLL in 2018


Canadian Perspective Discussion Period


Non-Hodgkin’s Lymphoma II / Chair: Dr. David Macdonald

Waldenstrom Macroglobulinemia - New Standards for Therapy


Anti-CD20 in 2018


Challenges in the Management of Mantle Cell Lymphoma


Myeloproliferative Neoplasms (MPNs) and Leukemia / Chair: Dr. Dennis Kim

Practical Issues in CML in 2018


MPN’s


DAY 2

Thrombosis Session I / Chair: Dr. Wendy Lim

Current Treatment of Thromboembolism in 2018


Update on Recent Practice-Changing Clinical Trials in Thrombosis


Management of Anticoagulant Associated Bleeding


Non Malignant Hematological Disorders/ Chair: Dr. Denis Soulières

Cell Therapy for Non Malignant Hematological Disorders


Update on Sickle Cell


Evaluating Organ Iron Overload in Hematological Disorders


Thrombosis Session II / Chair: Dr. Wendy Lim

VTE in Pregnancy